Acute akinesia in Parkinson disease
- 12 April 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (7) , 1162-1169
Abstract
Objective: To assess acute akinesia in patients with Parkinson disease (PD) (“acute akinesia” defined as a sudden deterioration in motor performance that persists for ≥48 hours despite treatment).Keywords
This publication has 19 references indexed in Scilit:
- January 13 Highlight and CommentaryNeurology, 2004
- Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA NeuronsPharmacological Reviews, 2003
- Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- The impact of systemic infection on the progression of neurodegenerative diseaseNature Reviews Neuroscience, 2003
- Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisisJournal of Neural Transmission, 1993
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- “On‐Off”–induced lethal hyperthermiaMovement Disorders, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Simultaneous determination of carbidopa, levodopa and 3,4-dihydroxyphenyl-acetic acid using high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- ParkinsonismNeurology, 1967